Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

This research included another cohort of patients; findings were presented in a poster at ... demonstrated that semaglutide treatment led to significant reductions in total medical costs ...

Being prescribed semaglutide for diabetes or weight management ... and the Simmons Lessell Professor of Ophthalmology at Harvard Medical School, and the study’s senior author.

If you’re thinking about semaglutide, start by having an open conversation with a medical professional. They can help you weigh the pros and cons, considering your personal health needs and goals.

Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...

Vivani Medical, Inc. (VANI), on Wednesday, announced promising preclinical data for its semaglutide implant in development for weight management in overweight patients. NPM-139 is a small ...

Weight loss with semaglutide is possible when you connect with medical professionals who focus on access to affordable medicine, all from the convenience of home. Join the ReflexMD community today ...

12 Due to these potential side effects, medical supervision is crucial when initiating and maintaining treatment with semaglutide. Incorporating lifestyle factors such as diet and exercise is ...

In addition, there are also challenges related to the differences between semaglutide and trizepatide. Mir Ali, MD, board-certified bariatric surgeon and medical director of MemorialCare Surgical ...

Semaglutide, the popular anti-obesity drug ... a professor of cardiovascular medicine at Harvard Medical School, and director of innovation in the Cardiovascular Division at Brigham and Women's ...